Retour
Prix ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (01541.HK)
Graphique du cours de l'action 01541.HK
IMMUNEONCO-B (01541.HK)
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
HK$5.43
-7.49%
$-0.44
Marché fermé: Jan 20, 16:00:00 HKT
Statistiques clés
Clôture préc.
$5.88
Prix d'ouverture
$5.87
Plage de la journée
$5.38 - $5.88
Plage de 52 semaines
$4.31 - $16.8
Volume
2.4M
Volume moyen
2.1M
BPA (TTM)
-0.93
Rendement en dividend
--
Capitalisation boursière
$2.2B
Qu’est-ce que IMMUNEONCO-B ?
ImmuneOnco Biopharmaceuticals (Shanghai), Inc. operates as an early-stage biopharmaceutical company which develops and commercializes novel cancer immunotherapeutic products. The company is headquartered in Shanghai, Shanghai and currently employs 195 full-time employees. The company went IPO on 2023-09-05. The firm's main businesses include the development of biotechnology for the systemic utilization of innate and adaptive immunity, and the development of next-generation tumor immunotherapies, which primarily focus on the adaptive immune system. The firm's core product IMM01 is an innovative CD47-targeted molecule. The firm mainly operates its businesses in the domestic and overseas markets.
Fonctionnalités
Stratégies de trading
Ressources
© 2025 Finture Development Limited. All rights reserved
